319 results
Page 7 of 16
6-K
EX-99.1
0s6 im69j
8 Aug 13
Live Filing
12:00am
6-K
EX-99.1
fl7s35znrzu
29 Jul 13
English Court of Appeal finds in favor of Teva on Copaxone® patent litigation and upholds validity of Copaxone patent until May 2015
12:00am
6-K
EX-99.1
308srt9m
26 Jul 13
Teva Provides Update on COPAXONE® Litigation
12:00am
6-K
EX-99.1
lgmlqo7i g6spigv
1 Jul 13
Live Filing
12:00am
6-K
EX-32.1
3e8354xitw49 yyrajzs
12 Jun 13
Live Filing
12:00am
6-K
EX-99
mzxzam916 3wn
30 May 13
TEVA ANNOUNCES FDA ACCEPTANCE OF sNDA FOR A HIGHER CONCENTRATION DOSE OF COPAXONE®GIVEN THREE TIMES A WEEK
12:00am
6-K
EX-99.1
og34fadqau0rqudr
8 May 13
Adasuve® (loxapine) inhalation powder is approved in the U.S. for the acute treatment of agitation associated with schizophrenia and bipolar disorder
12:00am
6-K
EX-32.1
3gsqialek8ffi
6 May 13
Live Filing
12:00am
6-K
iq1m6
2 May 13
Current report (foreign)
12:00am
6-K
EX-99.1
30of4il2n3y6xne631m
17 Apr 13
Data Reported Comparable Multiple Pregnancy Rates Among Patients Treated with Investigational Milprosa™ and Progesterone Vaginal Gel
12:00am
6-K
EX-99.1
uvjbz 3jsss
29 Mar 13
Live Filing
12:00am
CORRESP
blv27u
29 Mar 13
Correspondence with SEC
12:00am
6-K
EX-99.1
pu5vk tad73uewjl0
21 Mar 13
Live Filing
12:00am
6-K
EX-99.1
ocs roars
20 Mar 13
Live Filing
12:00am
6-K
EX-99.1
0jq sqig6
14 Mar 13
Teva to Present New Research on CNS Product Portfolio and Pipeline at 2013 American Academy of Neurology Annual Meeting
12:00am
6-K
EX-99.1
ubqqmxzle
6 Mar 13
Live Filing
12:00am
6-K
EX-99.1
b8s1nm8qmz ce
4 Mar 13
Live Filing
12:00am
6-K
EX-99.1
7h5uwy7w9p3txcy
22 Feb 13
Additional QNASL® (beclomethasone dipropionate) Nasal Aerosol Data to be Presented at Annual Allergy Meeting
12:00am
6-K
EX-99.1
t9lum6xnbz rd4pv4hu
11 Feb 13
Teva Pharmaceuticals Announces Appointment of Dr. Arie Belldegrun to Board of Directors
12:00am